Hypertension prophylaxis with omega-3 fatty acids in heart transplant recipients
AK Andreassen,
A Hartmann,
J Offstad,
O Geiran,
K Kvernebo,
and
S Simonsen
Department of Cardiology, National Hospital, Oslo, Norway.
OBJECTIVES: This study sought to determine whether omega-3 fatty acids act as hypertension prophylaxis in heart transplant recipients and have an impact on vascular reactivity. BACKGROUND: Cyclosporine-induced hypertension is probably related to endothelial dysfunction. Suggested vasodilatory mechanisms of omega-3 fatty acids may therefore be particularly beneficial in heart transplant recipients. METHODS: Heart transplant recipients were randomized to receive either 4 g of omega-3 fatty acids (treatment group, n = 14) daily or corn oil (placebo group, n = 14) from the fourth postoperative day. Twenty-four hour blood pressure monitoring was performed at day 12 and 1,2,3 and 6 months postoperatively. Microvascular endothelium-dependent vasodilation, evaluated by skin laser Doppler perfusion measurements of postocclusive reactive hyperemia, was determined preoperatively and at the end of the study. RESULTS: With comparable characteristics at the time of randomization, blood levels of cyclosporine did not at any point differ between the groups. After 6 months, systolic blood pressure decreased 2 +/- 4 mm Hg (mean +/- SEM) in the treatment group and increased 17 +/- 4 mm Hg in the placebo group (p < 0.01), whereas diastolic blood pressure increased 10 +/- 3 and 21 +/- 2 mm Hg (p < 0.01), respectively. The decrease in systolic blood pressure was inversely proportional to increases in concentrations of serum eicosapentaenoic and docosahexaenoic acid (p = 0.01). After 6 months, five patients in the treatment group and nine in the placebo group needed additional antihypertensive treatment. Although the endothelial-dependent phase of the reactive hyperemic response remained unchanged in the treatment group, it decreased significantly in the placebo group. CONCLUSIONS: Postoperative daily administration of 4 g of omega-3 fatty acids in heart transplant recipients is effective as hypertension prophylaxis, depending on increases in serum eicosapentaenoic and docosahexaenoic acids. Preservation of microvascular endothelial function, demonstrated by a more pronounced response to forearm skin ischemia in the treatment group, may contribute to the hypotensive role of omega-3 fatty acids.
This article has been cited by other articles:

|
 |

|
 |
 
R. A. Othman, M. Suh, G. Fischer, N. Azordegan, N. Riediger, K. Le, D. S. Jassal, and M. H. Moghadasian
A comparison of the effects of fish oil and flaxseed oil on cardiac allograft chronic rejection in rats
Am J Physiol Heart Circ Physiol,
March 1, 2008;
294(3):
H1452 - H1458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. U. Nwakanma, A. S. Shah, J. V. Conte, and W. A. Baumgartner
Heart Transplantation
Card. Surg. Adult,
January 1, 2008;
3(2008):
1539 - 1578.
[Full Text]
|
 |
|

|
 |

|
 |
 
B. T. Bethea, D. D. Yuh, J. V. Conte, and W. A. Baumgartner
Heart Transplantation
Card. Surg. Adult,
January 1, 2003;
2(2003):
1427 - 1460.
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Crone, G. Gabriel, and T. N. Wise
Non-Herbal Nutritional Supplements--The Next Wave: A Comprehensive Review of Risks and Benefits for the C-L Psychiatrist
Psychosomatics,
August 1, 2001;
42(4):
285 - 299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T Holm, A.K Andreassen, P Aukrust, K Andersen, O.R Geiran, J Kjekshus, S Simonsen, and L Gullestad
Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients
Eur. Heart J.,
March 1, 2001;
22(5):
428 - 436.
[Abstract]
[PDF]
|
 |
|
|